Goldman Sachs’s Moleculin Biotech MBRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q1
Sell
-788
Closed -$22K 5833
2021
Q4
$22K Buy
+788
New +$22K ﹤0.01% 5447
2021
Q3
Sell
-1,714
Closed -$94K 5461
2021
Q2
$94K Buy
+1,714
New +$94K ﹤0.01% 5134
2017
Q2
Sell
-195
Closed -$20K 4464
2017
Q1
$20K Buy
+195
New +$20K ﹤0.01% 4325